UBS O'Connor’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-20,850
| Closed | -$66.3K | – | 319 |
|
|
2025
Q1 | $66.3K | Sell |
20,850
-19,150
| -48% | -$60.9K | ﹤0.01% | 231 |
|
|
2024
Q4 | $214K | Buy |
+40,000
| New | +$214K | 0.01% | 307 |
|
|
2016
Q3 | – | Sell |
-20,000
| Closed | -$285K | – | 396 |
|
|
2016
Q2 | $285K | Sell |
20,000
-40,000
| -67% | -$570K | 0.01% | 356 |
|
|
2016
Q1 | $870K | Buy |
+60,000
| New | +$870K | 0.02% | 323 |
|